MediPharm Labs Corp.
No trades
No trades
Analyst rating
Based on 1 analyst giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of LABS is 0.070 CAD — it hasn't changed in the past 24 hours. Watch MediPharm Labs Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MediPharm Labs Corp. stocks are traded under the ticker LABS.
LABS stock has fallen by −6.67% compared to the previous week, the month change is a −6.67% fall, over the last year MediPharm Labs Corp. has showed a −6.67% decrease.
LABS reached its all-time high on May 14, 2019 with the price of 7.390 CAD, and its all-time low was 0.055 CAD and was reached on Jun 29, 2023. View more price dynamics on LABS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LABS stock is 0.00% volatile and has beta coefficient of 0.57. Track MediPharm Labs Corp. stock price on the chart and check out the list of the most volatile stocks — is MediPharm Labs Corp. there?
Yes, you can track MediPharm Labs Corp. financials in yearly and quarterly reports right on TradingView.
MediPharm Labs Corp. is going to release the next earnings report on Nov 16, 2026. Keep track of upcoming events with our Earnings Calendar.
MediPharm Labs Corp. revenue for the last quarter amounts to 9.98 M CAD, despite the estimated figure of 8.93 M CAD. In the next quarter, revenue is expected to reach 10.18 M CAD.
LABS net income for the last quarter is 4.00 K CAD, while the quarter before that showed −867.00 K CAD of net income which accounts for 0.00% change. Track more MediPharm Labs Corp. financial stats to get the full picture.
No, LABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 4, 2026, the company has 127 employees. See our rating of the largest employees — is MediPharm Labs Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediPharm Labs Corp. EBITDA is −3.43 M CAD, and current EBITDA margin is −15.48%. See more stats in MediPharm Labs Corp. financial statements.
Like other stocks, LABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediPharm Labs Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediPharm Labs Corp. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediPharm Labs Corp. stock shows the strong sell signal. See more of MediPharm Labs Corp. technicals for a more comprehensive analysis.